Local anesthetic derived from algae ‘effectively blocks pain in surgical patients’
February 24th, 2011 - 6:25 pm ICT by ANIWashington, Feb 24 (ANI): Surgical patients might soon benefit from a long-acting local anesthetic, thanks to researchers in the United States and Chile.
In a randomised, double-blind trial, patients had significantly less postoperative pain and recovered about two days sooner when they received neosaxitoxin, a new local anesthetic derived from algae.
Based on this finding, Children’s Hospital Boston, a co-investigator in the study, has signed an agreement to work with Proteus, a biotech start-up company in Chile, to move the new anesthetic toward clinical adoption.
Local anesthetics currently in use last for less than eight hours. When they wear off, patients generally need opioid analgesics, which cause side effects such as nausea, sedation, shallow breathing, constipation, sleepiness and itching.
The side effects often delay recovery and sometimes result in prolonged hospitalisation.
Neosaxitoxin (neoSTX), a site 1 sodium-channel blocker based on molecules derived from aquatic organisms, provides local anesthesia for more than 24 hours.
The trial, the first of its kind, involved 137 Chilean patients undergoing laparoscopic removal of their gall bladders.
Significantly, fewer patients randomised to neoSTX reported severe postoperative pain at the incision site at both 12 hours (4 percent vs. 18 percent) and 24 hours (6 percent vs. 16 percent).
In addition, more neoSTX-treated patients had complete absence of pain at 12 hours, both at rest (88 percent vs. 69 percent) and with movement (80 percent vs. 60 percent).
Patients in that group reported full functional recovery about two days earlier. Neither group reported serious adverse reactions.
“In my opinion, there has not been a truly innovative new local anesthetic medication in the last 40 to 50 years,” said study co-author Charles Berde, chief of the Division of Pain Medicine at Children’s Hospital Boston.
“Most drugs introduced over that time period have represented only minimal advances. There have been candidate drugs that went in novel directions, but they’ve had shortcomings, and none have made it to market,” he added.
The finding is reported in the March-April issue of Regional Anesthesia and Pain Medicine. (ANI)
- General anesthesia 'puts brain into a state of reversible coma, not sleep' - Dec 30, 2010
- 1 in 7 patients report more physical problems a year after surgery - Aug 26, 2010
- Conscious sedation for brain surgery may shorten hospital stay - Jun 19, 2010
- Patient swallows syringe, seeks fine from hospital - Apr 23, 2012
- Weight loss surgery can help alleviate migraines - Mar 29, 2011
- 'John of God' appears on Oprah's show - Nov 18, 2010
- Acupuncture the best bet to ease pain - May 02, 2010
- Anaesthesia jabs promise prolonged pain relief without toxicity - Apr 16, 2009
- Knee replacement surgeries take more time to conduct in overweight patients - Feb 19, 2011
- LEDs may help improve cognitive function after traumatic brain injury - Mar 18, 2011
- Women suffer pain more intensely than men - Jan 24, 2012
- Gargling with licorice solution can cut severity of post-surgery sore throat - Jun 20, 2009
- Cuba develops anti-arthritis drug - Feb 17, 2011
- Brain tumour treated with minimal invasive surgery - Feb 10, 2011
- Apex court issues notice on sterilisation (Lead) - Apr 02, 2012
Tags: adverse reactions, aquatic organisms, author charles, berde, co investigator, double blind trial, functional recovery, hospital boston, incision, local anesthesia, local anesthetic, local anesthetics, opioid analgesics, pain medicine, postoperative pain, s hospital, shallow breathing, sodium channel, start up company, surgical patients